Amy Goodman

2.3k total citations
34 papers, 1.5k citations indexed

About

Amy Goodman is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Amy Goodman has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 9 papers in Pathology and Forensic Medicine and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Amy Goodman's work include Migraine and Headache Studies (10 papers), Sympathectomy and Hyperhidrosis Treatments (7 papers) and Neonatal and fetal brain pathology (6 papers). Amy Goodman is often cited by papers focused on Migraine and Headache Studies (10 papers), Sympathectomy and Hyperhidrosis Treatments (7 papers) and Neonatal and fetal brain pathology (6 papers). Amy Goodman collaborates with scholars based in United States, Denmark and Germany. Amy Goodman's co-authors include Beth Paterson Smith, James F. Mooney, Sarah N. Mattson, Dean C. Delis, L. Andrew Koman, Edward P. Riley, Chip Caine, Anthony Caparso, Arne May and Rigmor Jensen and has published in prestigious journals such as Neurology, Annals of Oncology and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Amy Goodman

31 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Goodman United States 12 815 534 473 323 247 34 1.5k
Susan Hutchinson United States 18 1.4k 1.8× 200 0.4× 181 0.4× 617 1.9× 358 1.4× 56 1.8k
Tetsuo Koyama Japan 21 433 0.5× 325 0.6× 156 0.3× 87 0.3× 540 2.2× 103 2.1k
Andrew Schrepf United States 28 674 0.8× 120 0.2× 244 0.5× 60 0.2× 532 2.2× 96 2.2k
Rima M. Dafer United States 17 537 0.7× 349 0.7× 57 0.1× 159 0.5× 146 0.6× 51 1.4k
Kristina Tedroff Sweden 25 1.2k 1.4× 546 1.0× 649 1.4× 40 0.1× 29 0.1× 62 1.7k
Ilona Autti‐Rämö Finland 26 472 0.6× 440 0.8× 1.1k 2.3× 28 0.1× 55 0.2× 69 1.9k
Miles Levy United Kingdom 24 816 1.0× 140 0.3× 78 0.2× 631 2.0× 367 1.5× 79 2.1k
G. Cunin France 7 336 0.4× 615 1.2× 148 0.3× 365 1.1× 1.2k 4.9× 12 2.2k
Barbara I. Karp United States 25 472 0.6× 949 1.8× 97 0.2× 53 0.2× 147 0.6× 63 2.1k
Carol Vance United States 20 414 0.5× 313 0.6× 137 0.3× 82 0.3× 763 3.1× 44 2.0k

Countries citing papers authored by Amy Goodman

Since Specialization
Citations

This map shows the geographic impact of Amy Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Goodman more than expected).

Fields of papers citing papers by Amy Goodman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Goodman. The network helps show where Amy Goodman may publish in the future.

Co-authorship network of co-authors of Amy Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Goodman. A scholar is included among the top collaborators of Amy Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Goodman. Amy Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanborn, Rachel E., Minal Patel, Jordi Rodón, et al.. (2024). 991O First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors. Annals of Oncology. 35. S675–S676. 1 indexed citations
2.
Gonzalez, Fernando F., Bryan A. Comstock, Dennis E. Mayock, et al.. (2023). Placental Histologic Abnormalities and 2-Year Outcomes in Neonatal Hypoxic-Ischemic Encephalopathy. Neonatology. 120(6). 760–767. 6 indexed citations
3.
Benninger, Kristen, Terrie E. Inder, Amy Goodman, et al.. (2020). Perspectives from the Society for Pediatric Research. Neonatal encephalopathy clinical trials: developing the future. Pediatric Research. 89(1). 74–84. 19 indexed citations
4.
Wu, Tai-Wei, Amy Goodman, Taeun Chang, et al.. (2019). Placental pathology and neonatal brain MRI in a randomized trial of erythropoietin for hypoxic–ischemic encephalopathy. Pediatric Research. 87(5). 879–884. 27 indexed citations
5.
Juul, Sandra E., Bryan A. Comstock, Patrick J. Heagerty, et al.. (2018). High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial – Background, Aims, and Study Protocol. Neonatology. 113(4). 331–338. 94 indexed citations
6.
Barloese, Mads, Tim Jürgens, Arne May, et al.. (2016). Cluster headache attack remission with sphenopalatine ganglion stimulation: experiences in chronic cluster headache patients through 24 months. The Journal of Headache and Pain. 17(1). 67–67. 35 indexed citations
7.
Jürgens, Tim, Mads Barloese, Arne May, et al.. (2016). Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache. Cephalalgia. 37(5). 423–434. 93 indexed citations
8.
Láinez, Miguel J. A., Rigmor Jensen, Arne May, et al.. (2014). Long Term Therapeutic Response of Sphenopalatine Ganglion (SPG) Stimulation for Cluster Headache - Pathway CH-1 Study (I9-1.007). Neurology. 82(10_supplement). 2 indexed citations
9.
Láinez, Miguel J. A., Rigmor Jensen, Arne May, et al.. (2014). Long Term Therapeutic Response of Sphenopalatine Ganglion (SPG) Stimulation for Cluster Headache - Pathway CH-1 Study (P7.201). Neurology. 82(10_supplement). 3 indexed citations
10.
Schoenen, Jean, Arne May, Rigmor Jensen, et al.. (2013). Pathway ch-1 study: sphenopalatine ganglion (spg) stimulation for acute treatment of chronic cluster headache (CCH). The Journal of Headache and Pain. 1(Suppl 1). P57–P57. 3 indexed citations
11.
Paemeleire, Koen & Amy Goodman. (2012). Results of a patient survey for an implantable neurostimulator to treat migraine headaches. The Journal of Headache and Pain. 13(3). 239–241. 4 indexed citations
12.
Dixon, Jennifer A., Amy Goodman, William T. Rivers, et al.. (2011). Hemodynamics and myocardial blood flow patterns after placement of a cardiac passive restraint device in a model of dilated cardiomyopathy. Journal of Thoracic and Cardiovascular Surgery. 142(5). 1038–1045. 7 indexed citations
13.
Goodman, Amy & David Goodman. (2006). Static : government liars, media cheerleaders, and the people who fight back. 7 indexed citations
14.
Ridberg, Ronit & Amy Goodman. (2006). Big bucks, big pharma : marketing disease & pushing drugs. 1 indexed citations
15.
Goodman, Amy. (2005). The Middle School High Five: Strategies Can Triumph. Voices from the Middle. 13(2). 12–19. 3 indexed citations
16.
Goodman, Amy, Merlise A. Clyde, Donald S. Burdick, Salim F. Idriss, & Patrick D. Wolf. (2004). Minimum Energy Single-Shock Internal Atrial Defibrillation in Sheep. Journal of Interventional Cardiac Electrophysiology. 10(2). 131–138. 2 indexed citations
17.
Goodman, Amy. (2003). Independent media in a time of war. 24(1). 1. 1 indexed citations
18.
Goodman, Amy. (2003). Get A.C.T.I.V.E.: Engaging Middle School Readers with Text. Voices from the Middle. 11(1). 15–23. 1 indexed citations
19.
Mooney, James F., et al.. (1994). Management of Spasticity in Cerebral Palsy with Botulinum-A Toxin: Report of a Preliminary, Randomized, Double-Blind Trial. Journal of Pediatric Orthopaedics. 14(3). 299–303. 246 indexed citations
20.
Koman, L. Andrew, et al.. (1993). Management of Cerebral Palsy with Botulinum-A Toxin. Journal of Pediatric Orthopaedics. 13(4). 489–495. 326 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Hutchinson Breakdown of academic impact, for papers by Tetsuo Koyama Breakdown of academic impact, for papers by Andrew Schrepf Breakdown of academic impact, for papers by Rima M. Dafer Breakdown of academic impact, for papers by Kristina Tedroff Breakdown of academic impact, for papers by Ilona Autti‐Rämö Breakdown of academic impact, for papers by Miles Levy Breakdown of academic impact, for papers by G. Cunin Breakdown of academic impact, for papers by Barbara I. Karp Breakdown of academic impact, for papers by Carol Vance
Rankless by CCL
2026